The efficacy of intrauterine versus oral progestin for the treatment of endometrial hyperplasia. A prospective randomized comparative study

Clinical and Experimental Obstetrics and Gynecology

Volumn 40, Issue 1, 2013, Pages 122-126

  Dolapcioglu, K ^a   Boz, A ^b   Baloglu, A ^a  

^a MUSTAFA KEMAL UNIVERSITY   (Turkey)

^b Antakya Maternity Hospital   (Turkey)

Author keywords

Endometrial hyperplasia; Levonorgestrel releasing intrauterine system; Non atypical; Oral progestin; Theraphy

Indexed keywords

LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG TREATMENT FAILURE; ENDOMETRIUM BIOPSY; ENDOMETRIUM HYPERPLASIA; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; OPEN STUDY; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REMISSION; TREATMENT DURATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; CONTRACEPTIVE AGENTS, FEMALE; ENDOMETRIAL HYPERPLASIA; FEMALE; HUMANS; INTRAUTERINE DEVICES, MEDICATED; LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE; MIDDLE AGED; PATIENT SELECTION; PROGESTINS; PROSPECTIVE STUDIES; TREATMENT FAILURE;

EID: 84876253638     PISSN: 03906663     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. th ed. Lippincott Williams & Wilkins, Philadelphia, 2007, 1343.
2. Vereide A.B., Arnes M., Strame B., Maltau J.M., Krbo A.: "Nuclear morphometric changes and therapy monitoring in patients with endometrial hyperplasia: a study comparing effects of intrauterine levonorgestrel and systemic medroxyprogesterone". Gynecol. Oncol., 2003, 91, 526.
3. Kurman R., Kaminski P., Norris H.: "The behavior of endometrial hyperplasia: a long-term study of untreated hyperplasia in 170 patients". Cancer, 1985, 56, 403.
4. Hammond R., Johnson J.: "Endometrial hyperplasia". Curr. Obstet. Gynaecol., 2004, 14, 99.
5. Ferenczy A., Gelfand M.: "The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia". Am. J. Obstet. Gynecol., 1989, 160, 126.
6. Gal D., Edman C.D., Vellios F., Forney J.P.: "Long-term effect of megestrol acetate in the treatment of endometrial hyperplasia". Am. J. Obstet. Gynecol., 1983, 146, 316.
7. Randall T.C., Kurman R.J.: "Progestin treatment of atypical hyperplasia and well-differentiated carcinoma of the endometrium in women under age 40". Obstet. Gynecol., 1987, 90, 434.
8. Schulz K.F., Altman D.G., Moher D.: "CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials". BMC Medicine, 2010, 8, 18.
9. Vereide A.B., Kaino T., Sager G., Arnes M., Krbo A.: "Effect of levonorgestrel IUD and oral medroxyprogesterone acetate on glandular and stromal progesterone receptors (PRA and PRB) and estrogen receptors (ER-a and ER-β) in human endometrial hyperplasia". Gynecol. Oncol., 2006, 101, 214.
10. Wildemeersch D., Dhont M.: "Treatment of nonatypical and atypical endometrial hyperplasia with levonorgestrel-releasing intrauterine system". Am. J. Obstet. Gynecol., 2002, 188, 1297.
11. Wildemeersch D., Janssens D., Pylyser K., deWever N., Verbeeck G., Dhont M. et al.: "Management of patients with nonatypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up". Maturitas, 2007, 57, 210.
12. Scarselli G., Tantini C., Colafranceschi M., Taddei G.L., Bargelli G., Venturini N., Branconi F.: "Levo-norgestrel-nova-T and precancerous lesions of the endometrium". Eur. J. Gynaecol. Oncol., 1988, 9, 284.
13. Nilsson C.G., Haukkamaa M., Vierola H., Luukkainen T.: "Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD". Clin. Endocrinol. (Oxf.), 1982, 17, 529.
14. Orbo A., Arnes M., Hancke C., Vereide A.B., Pettersen I., Larsen K.: "Treatment results of endometrial hyperplasia after prospective D-score classification: a follow-up study comparing effect of LNG-IUD and oral progestins versus observation only". Gynecol. Oncol., 2008, 111, 68.
15. Wheleer D.T., Bristow R.E., Kurman R.J.: "Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins". Am. J. Surg. Path., 2007, 31, 988.
16. Buttini M.J., Jordan S.J., Webb P.M.: "The effect of the levonorgestrel releasing intrauterine system on endometrial hyperplasia: an Australian study and systematic review". Aust. NZJ Obstet. Gynaecol., 2009, 49, 316.
17. Clark T.J., Neelakantan D., Gupta J.K.: "The management of endometrial hyperplasia: an evaluation of current practice". Eur. J. Obstet. Gynecol. Reprod. Biol., 2006, 125, 259.
18. Varma R., Soneja H., Bhatia K., Ganesan R., Rollason T., Clark T.J. et al.: "The effectiveness of a levonorgestrel-releasing intrauterine system (LNG-IUS) in the treatment of endometrial hyperplasia- a long-term follow-up study". Eur. J. Obstet. Gynecol. Reprod. Biol., 2008, 139, 169.
19. Lee S.Y., Kim M.K., Park H, Yoon B.S.: "The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women". J. Gynecol. Oncol., 2010, 21, 102.